The Downstream Column (DsC) is an online publication targeting members of the biologics industry. Our intent is to provide a community to share expertise and best practices as well as discuss topics of interest. The Downstream Column covers areas important to the research, discovery, development, and manufacture of biologic therapeutics. Key industry coverage areas include: purification, formulation, fill/finish, and QA/QC for cell and gene therapies, vaccines, biologics, and emerging therapeutic modalities.
All content for The Downstream Column Podcast is the property of Brandy Sargent and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
The Downstream Column (DsC) is an online publication targeting members of the biologics industry. Our intent is to provide a community to share expertise and best practices as well as discuss topics of interest. The Downstream Column covers areas important to the research, discovery, development, and manufacture of biologic therapeutics. Key industry coverage areas include: purification, formulation, fill/finish, and QA/QC for cell and gene therapies, vaccines, biologics, and emerging therapeutic modalities.
Protein A Chromatography – A look at where we have been and where we are going
The Downstream Column Podcast
25 minutes 38 seconds
7 years ago
Protein A Chromatography – A look at where we have been and where we are going
In this podcast, we interviewed Jonathan Royce, Business Leader, Chromatography Resins, GE Healthcare Life Sciences, about the evolution of Protein A including the latest developments in Protein A chromatography resins. We also discussed what the future holds for this purification mainstay and how it can continue to address the changing needs of biopharma.
View show notes at downstreamcolumn.com/podcast/protein-chromatography-look-going/
The Downstream Column Podcast
The Downstream Column (DsC) is an online publication targeting members of the biologics industry. Our intent is to provide a community to share expertise and best practices as well as discuss topics of interest. The Downstream Column covers areas important to the research, discovery, development, and manufacture of biologic therapeutics. Key industry coverage areas include: purification, formulation, fill/finish, and QA/QC for cell and gene therapies, vaccines, biologics, and emerging therapeutic modalities.
